Back

Association between yangxinshi and 1-year all-cause mortality in patients with coronary artery disease without prior cardiovascular events

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Complex coronary syndromes: novel risk markers, comorbidities, and clinical outcomes Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Kang-Yin Chen

2nd Hospital of Tianjin Medical University, Tianjin (China)

4 More presentations in this session

Presentation thumbnail
Early hospital readmission after coronary artery bypass grafting in men and women: a retrospective cohort study
Miss M. Maiolino De Carvalho (BR)
Abstract
Presentation thumbnail
Obesity and diabetes, two important modifiable prognostic risk factors after myocardial infarction in women
Doctor V. Ritsinger (Stockholm, SE)
Abstract
Presentation thumbnail
The novel use of Transcutaneous Electrical Nerve Stimulation (TENS) in patients with persistent angina due to coronary artery spasm; a pilot study
Miss F. Vervaat (Eindhoven, NL)
Abstract
Presentation thumbnail
Impact of prior coronary revascularisation on clinical presentation and one-year outcomes in acute coronary syndrome
Doctor K. Ichihara (Kobe, JP)
Abstract

Access the full session

Session thumbnail
Complex coronary syndromes: novel risk markers, comorbidities, and clinical outcomes

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Predicting mortality in patients with heart failure and obstructive chronic coronary syndrome
21 May 2023
thumbnail
Congress Presentation
Impact of statin therapy on mortality in chronic kidney disease patients without atherosclerotic cardiovascular disease: insights from american and chinese cohorts (MIMIC-IV and CIN-II Databases)
29 August 2025
thumbnail
Congress Presentation
Time and cause of death in patients after acute coronary syndrome
1 September 2024
thumbnail
Congress Presentation
Reduction of cardiovascular events in patients with cardiovascular disease with the CV-polypill: a retrospective and propensity score matching study
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources